Similar articles

• [Behavior of prostate-specific antigen (PSA) in prostate tissue: correlation with prostatic acid phosphatase (PAP)].

  Morote Robles J, Segura RM, De Torres JA, Soler Roselló A. Morote Robles J, et al. Actas Urol Esp. 1987 Mar-Apr;11(2):180-3. Actas Urol Esp. 1987. PMID: 2441576 Spanish. No abstract available.
• Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.

  Kuriyama M, Wang MC, Lee CL, Killian CS, Papsidero LD, Inaji H, Loor RM, Lin MF, Nishiura T, Slack NH, Murphy GP, Chu TM. Kuriyama M, et al. J Natl Cancer Inst. 1982 Jan;68(1):99-105. J Natl Cancer Inst. 1982. PMID: 6172628
• Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization: implications for immunotherapy of prostate cancer.

  Fong L, Ruegg CL, Brockstedt D, Engleman EG, Laus R. Fong L, et al. J Immunol. 1997 Oct 1;159(7):3113-7. J Immunol. 1997. PMID: 9317107
• [Prostate-specific antigen as a tumor marker of prostate carcinoma].

  Wymenga LF, Mensink HJ. Wymenga LF, et al. Ned Tijdschr Geneeskd. 1999 Aug 21;143(34):1733-8. Ned Tijdschr Geneeskd. 1999. PMID: 10494319 Review. Dutch.
• Clinical and experimental considerations of the immunologic response to prostatic and other accessory glands tissues of reproduction.

  Ablin RJ, Soanes WA, Gonder MJ. Ablin RJ, et al. Urol Int. 1970;25(5):511-39. doi: 10.1159/000279702. Urol Int. 1970. PMID: 4111980 Review. No abstract available.